Help Center
PI3K
What is PI3K?
Phosphoinositide 3-kinases (PI3Ks) are a family of lipid kinases that phosphorylate phosphatidylinositol lipids to regulate cell growth, survival, metabolism, and immune signaling. PI3K activation leads to downstream AKT and mTOR pathway signaling.
Aberrant PI3K signaling is frequently observed in cancer due to PIK3CA mutations, PTEN loss, or receptor tyrosine kinase activation.
What are the different PI3K isoforms?
Class I PI3Ks include four catalytic isoforms:
PI3Kα (PIK3CA)
PI3Kβ (PIK3CB)
PI3Kδ (PIK3CD)
PI3Kγ (PIK3CG)
PI3Kα and β are broadly expressed, while PI3Kδ and γ are enriched in leukocytes and play critical roles in immune regulation.
Isoform selectivity is an important consideration in drug development due to toxicity and immune effects.
What are the major types of PI3K inhibitors?
PI3K inhibitors can be classified as:
Pan-PI3K inhibitors
Isoform-selective inhibitors (α, β, δ, γ)
Dual PI3K/mTOR inhibitors
Irreversible inhibitors
Selectivity influences therapeutic window and toxicity profile.
How do PI3K inhibitors differ from mTOR inhibitors?
While PI3K inhibitors block upstream lipid kinase activity, mTOR inhibitors act downstream at the level of mTORC1 or mTORC2.
Dual PI3K/mTOR inhibitors target both nodes of the pathway and may achieve broader pathway suppression.
Biosimilar Antibodies
What are Biosimilar Antibodies?
Biosimilar antibodies are research-grade recombinant antibodies designed to closely resemble approved therapeutic antibodies in terms of amino acid sequence, structural characteristics, and biological activity. These antibodies are generated using recombinant expression technologies and retain the same variable regions as their corresponding reference therapeutics, thereby preserving target specificity and binding affinity. Owing to these properties, biosimilar antibodies serve as reliable and cost-effective research reagents for applications in drug discovery, pharmacological studies, and basic biomedical research.
Research-grade biosimilar antibodies have been successfully expressed and functionally validated against a wide range of widely studied targets. These antibodies can be directly utilized as positive control reagents in drug discovery programs, as well as reference tools for rapid verification of the biological functions of target proteins in biochemical and cellular assays.

